OREGON HEALTH & SCIENCE UNIVERSITY
Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes
Leveraging Biologically Specific PET/MRI Monitoring and Therapeutic Modulation of the Hypoxic Glioblastoma Tumor Immune Microenvironment into Improved Outcomes is a funding opportunity from OREGON HEALTH & SCIENCE UNIVERSITY, up to 541069, closing April 30, 2029.
Apr 30, 2029
(1004d left)Overview
ABSTRACT Leveraging neuroinflammation to improve treatment outcomes for patients with glioblastoma is challenging because the hypoxic tumor immune microenvironment (TIME), mostly comprised of immuno-suppressive tumor-associated macrophages (TAMs), remains incompletely quantified and therapeutically modulated. The…